NCT01887990View on ClinicalTrials.gov

Treatment of Suicidal Ideation With Intravenous Ketamine Infusion

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
DepressionSuicidal Ideation
Interventions
DRUG

Ketamine

single dose IV 0.2 mg/kg ketamine

DRUG

placebo

saline infusion

Trial Locations (1)

35205

University of Alabama Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT01887990 - Treatment of Suicidal Ideation With Intravenous Ketamine Infusion | Biotech Hunter | Biotech Hunter